INVA (Innoviva) Short Interest


INVA Innoviva Inc INVA
89 GF Score
Price $23.64
GF Value $20.37
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Innoviva Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

INVA vs IMTX, VIR, PGEN: Short Interest Comparison

For the Biotechnology subindustry, Innoviva's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innoviva Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innoviva's Short Interest distribution charts can be found below:

* The bar in red indicates where Innoviva's Short Interest falls into.


INVA
89GF Score
Innoviva Inc INVA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Innoviva (INVA) Overvalued in 2026?

Based on GuruFocus' analysis, Innoviva stock appears to be overvalued. The current stock price of $23.64 is trading 16.1% above its estimated GF Value™ of $20.37. GuruFocus considers Innoviva to be Modestly Overvalued.

Key valuation signals for INVA:

  • Short Interest:
  • GF Value™: $20.37 vs. price of $23.64 (16.1% above fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the INVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Innoviva Business Description

Other Exchanges HVE:Germany
Address 1350 Old Bayshore Highway, Suite 400, Burlingame, CA, USA, 94010
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
89GF Score

Get the complete analysis for INVA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.64
Price
$20.37
GF Value